» Articles » PMID: 12663476

Is Podocyte Injury Relevant in Diabetic Nephropathy? Studies in Patients with Type 2 Diabetes

Overview
Journal Diabetes
Specialty Endocrinology
Date 2003 Mar 29
PMID 12663476
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

Podocyte structural changes have been suggested to be involved in the pathogenesis of albuminuria in diabetes. We evaluated podocytes density, number, and structure in 67 white patients with type 2 diabetes: 21 normoalbuminuric (NA), 23 microalbuminuric (MA), and 23 proteinuric (P). Kidney function and biopsy studies were performed; 20 kidney donors served as control subjects. Electron microscopic morphometric analysis was used to estimate numerical density of podocytes per glomerulus [Nv(epi/glom)], filtration slit length density per glomerulus (FSLv/glom), and foot process width (FPW). The number of podocytes per glomerulus (Epi N/glom) was obtained by multiplying Nv(epi/glom) by mean glomerular volume. Nv(epi/glom) was significantly decreased in all type 2 diabetic groups compared with control subjects and was lower in MA and P than in NA (P < 0.0001, ANOVA). Epi N/glom was lower in MA and P patients compared with control subjects (P < 0.002, ANOVA); however, there were no significant differences among the type 2 diabetic groups. In addition, MA and P had decreased FSLv/glom and increased FPW compared with NA (P < 0.005 for both, ANOVA). The albumin excretion rate was inversely related to Nv(epi/glom) and FSLv/glom and directly to FPW (P < 0.0005 for all), whereas there was no correlation with Epi N/glom. In conclusion, changes in podocyte structure and density occur since the early stages of diabetic nephropathy and might contribute to increasing albuminuria in type 2 diabetic patients. These findings also suggest that in white type 2 diabetic patients, the density of podocytes may be functionally more relevant than the absolute number.

Citing Articles

O-linked β-N-acetylglucosamine (O-GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy.

Qi B, Chen Y, Chai S, Lu X, Kang L Diabet Med. 2024; 42(2):e15436.

PMID: 39279604 PMC: 11733667. DOI: 10.1111/dme.15436.


Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus.

Shukla A, Awasthi K, Usman K, Banerjee M World J Diabetes. 2024; 15(4):606-622.

PMID: 38680697 PMC: 11045416. DOI: 10.4239/wjd.v15.i4.606.


The potential role of differentially expressed tRNA-derived fragments in high glucose-induced podocytes.

Zhang Z, Qiao Y, Ji J, Huang C, Shi H, Gan W Ren Fail. 2024; 46(1):2318413.

PMID: 38369750 PMC: 10878346. DOI: 10.1080/0886022X.2024.2318413.


Combined Placental Mesenchymal Stem Cells with Guided Nanoparticles Effective Against Diabetic Nephropathy in Mouse Model.

Wang K, Liu T, Zhang Y, Lv H, Yao H, Zhao Y Int J Nanomedicine. 2024; 19:901-915.

PMID: 38293609 PMC: 10826715. DOI: 10.2147/IJN.S446733.


Effects and mechanism of Rictor interference in podocyte injury induced by high glucose.

Zeng Y, Xiong C, Chen Y, Yang C, Li Q Exp Ther Med. 2023; 26(4):473.

PMID: 37753299 PMC: 10518650. DOI: 10.3892/etm.2023.12172.